Post-approval studies (Phase 4)Ended earlyNCT01346865
What this trial is testing
Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)
Who this might be right for
Coronary Artery Disease
Seung-Jung Park 402